US-toy giant Mattel has reached a settlement in a Federal Court case alleging its Mecard toys infringed on a patent for a toy transformation mechanism owned by Canadian toy company Spin Master.
The operator of a Vietnamese mine has filed a lawsuit seeking to enforce a $132 million arbitration judgment against engineering company Jacobs E&C, which was acquired by WorleyParsons in December.
Former Aussie Home Loans boss Stephen Porges has lost an appeal of a judgment ordering him to pay more than $1 million to a private equity firm that was found to have been duped into buying his worthless shares in a beleaguered startup.
Singapore-based cable manufacturer Midland Metals has lost its appeal of a judgment that found the Australian Cablemakers Association did not violate the consumer laws when it sent letters to several Ministers complaining that an electrical cable supplied by Midland was unsafe.
International law firm Baker McKenzie has confimed the death of its global chair, Paul Rawlinson, who had been on extended leave, citing exhaustion.
The head of Herbert Smith Freehills’ Australian international arbitration practice has become the first female to lead the Australian Centre for International Commercial Arbitration.
James Cook University unlawfully dismissed a professor who spoke out against the school and one of its scientists over its climate change views, a judge found Tuesday.
A director of an energy company who was kicked off the board for missing too many meetings has filed an appeal of a ruling dismissing his case over delays in complying with court requests after his lawyer from Maddocks withdrew from the case due to late payments.
An Australian marketing company that allows clients to schedule socal media posts has won a temporary court injunction against Facebook and Instagram in a lawsuit alleging a decision to block the startup from their platforms is a misuse of market power.
Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.